Global Circular RNA Synthesis Service Market 2026 by Company, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global Circular RNA Synthesis Service market size was valued at US$ 47.33 million in 2025 and is forecast to a readjusted size of US$ 234 million by 2032 with a CAGR of 25.2% during review period.
Circular RNA synthesis services provide integrated technical support for the design, production, purification, and quality control of customized circular RNA molecules based on customer-defined or jointly optimized target sequences. The typical service workflow includes circular RNA sequence design, DNA template construction, in vitro transcription, RNA circularization, purification, analytical testing, and optional lipid nanoparticle formulation and clinical-grade manufacturing. Major circularization routes include PIE self-splicing, modified scarless PIE methods, and T4 RNA ligase-mediated enzymatic ligation. Deliverables include research-grade circular RNA samples, preclinical drug substance, process-development packages, and GMP clinical batches. Upstream inputs mainly include nucleotide triphosphates, modified nucleosides, DNA and plasmid templates, RNA polymerases, RNA ligases, ribozyme elements, nucleases, buffers, chromatography media, ultrafiltration consumables, single-use bioprocessing materials, analytical reagents, and lipid materials, while downstream customers primarily include RNA drug developers, vaccine companies, gene and cell therapy companies, pharmaceutical companies, universities, research institutions, and hospital research centers. The overall industry gross margin typically around 40%?60%.
The circular RNA synthesis services market is still dominated by research-grade and preclinical projects, although demand is shifting from basic sample preparation toward sequence optimization, circularization process development, impurity control, analytical method establishment, and clinical manufacturing. The early market was primarily served by life-science tools and gene-synthesis companies supplying microgram- to milligram-scale customized samples. As circular RNA drugs, vaccines, and in vivo cell therapy programs advance, several integrated RNA service providers are developing gram-scale production, lipid nanoparticle formulation, and GMP-compliant manufacturing capabilities. Global supply is currently concentrated in China and the United States. Chinese providers have established broad capabilities in research services, sequence analysis, circularization process development, and integrated CRDMO support, while U.S.-based providers generally benefit from broader international customer coverage and established nucleic acid manufacturing infrastructure.
Future competition will shift from demonstrating basic circularization capability toward reliably delivering high-purity, translatable, low-immunogenicity products that meet regulatory requirements. Competitive differentiation will increasingly depend on scarless circularization, long-sequence compatibility, process robustness across different payloads, removal of double-stranded RNA and linear precursors, batch reproducibility, and biological potency testing. Research-grade projects will continue to account for a large number of orders, but most value growth is expected to come from preclinical process development, GMP manufacturing, analytical validation, and LNP formulation. Suppliers with integrated capabilities covering sequence design, template preparation, circularization, purification, analytics, and formulation will be better positioned to retain projects as they progress toward clinical development.
Market growth is being driven by the expanding development of circular RNA therapeutics, therapeutic vaccines, protein-expression therapies, in vivo CAR-T, and other gene and cell therapy applications. Compared with building an internal small-scale production platform, outsourcing to specialized providers gives developers access to validated circularization elements, process expertise, analytical methods, and scale-up equipment, helping reduce development risk and shorten timelines to animal studies and regulatory submissions. As projects move from discovery into preclinical and clinical stages, additional testing for purity, integrity, residual DNA, double-stranded RNA, endotoxin, sterility, and potency increases the value of individual service contracts. Continued interest from large pharmaceutical companies in next-generation RNA technologies may also support greater demand for platform collaboration and outsourced manufacturing.
The main barriers are the lack of harmonized technical standards and differences in how suppliers measure circularization rate, purity, integrity, and expression activity, which make direct service comparison difficult. Conventional PIE methods may introduce residual sequences, sequence restrictions, and unwanted by-products, while ligase-based methods face challenges related to enzyme cost, terminal design, and scale-up. Circularization efficiency, purification recovery, and batch consistency for long RNA sequences still require improvement. Clinical-grade production also requires more stringent raw-material controls, validated analytical methods, and quality standards. In addition, the limited number of clinical-stage downstream programs results in low GMP capacity utilization, exposing suppliers to high capital requirements, uneven order flow, and project cancellation risks.
This report is a detailed and comprehensive analysis for global Circular RNA Synthesis Service market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Circular RNA Synthesis Service market size and forecasts, in consumption value ($ Million), 2021-2032
Global Circular RNA Synthesis Service market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Circular RNA Synthesis Service market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Circular RNA Synthesis Service market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Circular RNA Synthesis Service market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Circular RNA Synthesis Service product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Circular RNA Synthesis Service, with revenue, gross margin, and global market share of Circular RNA Synthesis Service from 2021 to 2026.
Chapter 3, the Circular RNA Synthesis Service competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Circular RNA Synthesis Service market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Circular RNA Synthesis Service.
Chapter 13, to describe Circular RNA Synthesis Service research findings and conclusion.
Circular RNA synthesis services provide integrated technical support for the design, production, purification, and quality control of customized circular RNA molecules based on customer-defined or jointly optimized target sequences. The typical service workflow includes circular RNA sequence design, DNA template construction, in vitro transcription, RNA circularization, purification, analytical testing, and optional lipid nanoparticle formulation and clinical-grade manufacturing. Major circularization routes include PIE self-splicing, modified scarless PIE methods, and T4 RNA ligase-mediated enzymatic ligation. Deliverables include research-grade circular RNA samples, preclinical drug substance, process-development packages, and GMP clinical batches. Upstream inputs mainly include nucleotide triphosphates, modified nucleosides, DNA and plasmid templates, RNA polymerases, RNA ligases, ribozyme elements, nucleases, buffers, chromatography media, ultrafiltration consumables, single-use bioprocessing materials, analytical reagents, and lipid materials, while downstream customers primarily include RNA drug developers, vaccine companies, gene and cell therapy companies, pharmaceutical companies, universities, research institutions, and hospital research centers. The overall industry gross margin typically around 40%?60%.
The circular RNA synthesis services market is still dominated by research-grade and preclinical projects, although demand is shifting from basic sample preparation toward sequence optimization, circularization process development, impurity control, analytical method establishment, and clinical manufacturing. The early market was primarily served by life-science tools and gene-synthesis companies supplying microgram- to milligram-scale customized samples. As circular RNA drugs, vaccines, and in vivo cell therapy programs advance, several integrated RNA service providers are developing gram-scale production, lipid nanoparticle formulation, and GMP-compliant manufacturing capabilities. Global supply is currently concentrated in China and the United States. Chinese providers have established broad capabilities in research services, sequence analysis, circularization process development, and integrated CRDMO support, while U.S.-based providers generally benefit from broader international customer coverage and established nucleic acid manufacturing infrastructure.
Future competition will shift from demonstrating basic circularization capability toward reliably delivering high-purity, translatable, low-immunogenicity products that meet regulatory requirements. Competitive differentiation will increasingly depend on scarless circularization, long-sequence compatibility, process robustness across different payloads, removal of double-stranded RNA and linear precursors, batch reproducibility, and biological potency testing. Research-grade projects will continue to account for a large number of orders, but most value growth is expected to come from preclinical process development, GMP manufacturing, analytical validation, and LNP formulation. Suppliers with integrated capabilities covering sequence design, template preparation, circularization, purification, analytics, and formulation will be better positioned to retain projects as they progress toward clinical development.
Market growth is being driven by the expanding development of circular RNA therapeutics, therapeutic vaccines, protein-expression therapies, in vivo CAR-T, and other gene and cell therapy applications. Compared with building an internal small-scale production platform, outsourcing to specialized providers gives developers access to validated circularization elements, process expertise, analytical methods, and scale-up equipment, helping reduce development risk and shorten timelines to animal studies and regulatory submissions. As projects move from discovery into preclinical and clinical stages, additional testing for purity, integrity, residual DNA, double-stranded RNA, endotoxin, sterility, and potency increases the value of individual service contracts. Continued interest from large pharmaceutical companies in next-generation RNA technologies may also support greater demand for platform collaboration and outsourced manufacturing.
The main barriers are the lack of harmonized technical standards and differences in how suppliers measure circularization rate, purity, integrity, and expression activity, which make direct service comparison difficult. Conventional PIE methods may introduce residual sequences, sequence restrictions, and unwanted by-products, while ligase-based methods face challenges related to enzyme cost, terminal design, and scale-up. Circularization efficiency, purification recovery, and batch consistency for long RNA sequences still require improvement. Clinical-grade production also requires more stringent raw-material controls, validated analytical methods, and quality standards. In addition, the limited number of clinical-stage downstream programs results in low GMP capacity utilization, exposing suppliers to high capital requirements, uneven order flow, and project cancellation risks.
This report is a detailed and comprehensive analysis for global Circular RNA Synthesis Service market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Circular RNA Synthesis Service market size and forecasts, in consumption value ($ Million), 2021-2032
Global Circular RNA Synthesis Service market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Circular RNA Synthesis Service market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Circular RNA Synthesis Service market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
- To determine the size of the total market opportunity of global and key countries
- To assess the growth potential for Circular RNA Synthesis Service
- To forecast future growth in each product and end-use market
- To assess competitive factors affecting the marketplace
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Circular RNA Synthesis Service market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Custom Synthesis
- Process Development
- Analytical and QC Services
- Other
- PIE Circularization
- Enzymatic Ligation
- Other
- Naked circRNA
- circRNA-LNP
- Other
- Pharmaceutical and Biotechnology Companies
- CRO and CDMO Companies
- Other
- GenScript Biotech Corporation
- VectorBuilder
- Guangzhou Geneseed Biotech
- uBriGene Biosciences
- Yaohai Bio-Pharma
- Creative Biogene
- Creative Biolabs
- BOC Sciences
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Circular RNA Synthesis Service product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Circular RNA Synthesis Service, with revenue, gross margin, and global market share of Circular RNA Synthesis Service from 2021 to 2026.
Chapter 3, the Circular RNA Synthesis Service competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Circular RNA Synthesis Service market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Circular RNA Synthesis Service.
Chapter 13, to describe Circular RNA Synthesis Service research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Circular RNA Synthesis Service by Type
1.3.1 Overview: Global Circular RNA Synthesis Service Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global Circular RNA Synthesis Service Consumption Value Market Share by Type in 2025
1.3.3 Custom Synthesis
1.3.4 Process Development
1.3.5 Analytical and QC Services
1.3.6 Other
1.4 Classification of Circular RNA Synthesis Service by Circularization Method
1.4.1 Overview: Global Circular RNA Synthesis Service Market Size by Circularization Method: 2021 Versus 2025 Versus 2032
1.4.2 Global Circular RNA Synthesis Service Consumption Value Market Share by Circularization Method in 2025
1.4.3 PIE Circularization
1.4.4 Enzymatic Ligation
1.4.5 Other
1.5 Classification of Circular RNA Synthesis Service by Product Format
1.5.1 Overview: Global Circular RNA Synthesis Service Market Size by Product Format: 2021 Versus 2025 Versus 2032
1.5.2 Global Circular RNA Synthesis Service Consumption Value Market Share by Product Format in 2025
1.5.3 Naked circRNA
1.5.4 circRNA-LNP
1.5.5 Other
1.6 Global Circular RNA Synthesis Service Market by Application
1.6.1 Overview: Global Circular RNA Synthesis Service Market Size by Application: 2021 Versus 2025 Versus 2032
1.6.2 Pharmaceutical and Biotechnology Companies
1.6.3 CRO and CDMO Companies
1.6.4 Other
1.7 Global Circular RNA Synthesis Service Market Size & Forecast
1.8 Global Circular RNA Synthesis Service Market Size and Forecast by Region
1.8.1 Global Circular RNA Synthesis Service Market Size by Region: 2021 VS 2025 VS 2032
1.8.2 Global Circular RNA Synthesis Service Market Size by Region, (2021-2032)
1.8.3 North America Circular RNA Synthesis Service Market Size and Prospect (2021-2032)
1.8.4 Europe Circular RNA Synthesis Service Market Size and Prospect (2021-2032)
1.8.5 Asia-Pacific Circular RNA Synthesis Service Market Size and Prospect (2021-2032)
1.8.6 South America Circular RNA Synthesis Service Market Size and Prospect (2021-2032)
1.8.7 Middle East & Africa Circular RNA Synthesis Service Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 GenScript Biotech Corporation
2.1.1 GenScript Biotech Corporation Details
2.1.2 GenScript Biotech Corporation Major Business
2.1.3 GenScript Biotech Corporation Circular RNA Synthesis Service Product and Solutions
2.1.4 GenScript Biotech Corporation Circular RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 GenScript Biotech Corporation Recent Developments and Future Plans
2.2 VectorBuilder
2.2.1 VectorBuilder Details
2.2.2 VectorBuilder Major Business
2.2.3 VectorBuilder Circular RNA Synthesis Service Product and Solutions
2.2.4 VectorBuilder Circular RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 VectorBuilder Recent Developments and Future Plans
2.3 Guangzhou Geneseed Biotech
2.3.1 Guangzhou Geneseed Biotech Details
2.3.2 Guangzhou Geneseed Biotech Major Business
2.3.3 Guangzhou Geneseed Biotech Circular RNA Synthesis Service Product and Solutions
2.3.4 Guangzhou Geneseed Biotech Circular RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Guangzhou Geneseed Biotech Recent Developments and Future Plans
2.4 uBriGene Biosciences
2.4.1 uBriGene Biosciences Details
2.4.2 uBriGene Biosciences Major Business
2.4.3 uBriGene Biosciences Circular RNA Synthesis Service Product and Solutions
2.4.4 uBriGene Biosciences Circular RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 uBriGene Biosciences Recent Developments and Future Plans
2.5 Yaohai Bio-Pharma
2.5.1 Yaohai Bio-Pharma Details
2.5.2 Yaohai Bio-Pharma Major Business
2.5.3 Yaohai Bio-Pharma Circular RNA Synthesis Service Product and Solutions
2.5.4 Yaohai Bio-Pharma Circular RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Yaohai Bio-Pharma Recent Developments and Future Plans
2.6 Creative Biogene
2.6.1 Creative Biogene Details
2.6.2 Creative Biogene Major Business
2.6.3 Creative Biogene Circular RNA Synthesis Service Product and Solutions
2.6.4 Creative Biogene Circular RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Creative Biogene Recent Developments and Future Plans
2.7 Creative Biolabs
2.7.1 Creative Biolabs Details
2.7.2 Creative Biolabs Major Business
2.7.3 Creative Biolabs Circular RNA Synthesis Service Product and Solutions
2.7.4 Creative Biolabs Circular RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Creative Biolabs Recent Developments and Future Plans
2.8 BOC Sciences
2.8.1 BOC Sciences Details
2.8.2 BOC Sciences Major Business
2.8.3 BOC Sciences Circular RNA Synthesis Service Product and Solutions
2.8.4 BOC Sciences Circular RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 BOC Sciences Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Circular RNA Synthesis Service Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of Circular RNA Synthesis Service by Company Revenue
3.2.2 Top 3 Circular RNA Synthesis Service Players Market Share in 2025
3.2.3 Top 6 Circular RNA Synthesis Service Players Market Share in 2025
3.3 Circular RNA Synthesis Service Market: Overall Company Footprint Analysis
3.3.1 Circular RNA Synthesis Service Market: Region Footprint
3.3.2 Circular RNA Synthesis Service Market: Company Product Type Footprint
3.3.3 Circular RNA Synthesis Service Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Circular RNA Synthesis Service Consumption Value and Market Share by Type (2021-2026)
4.2 Global Circular RNA Synthesis Service Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Circular RNA Synthesis Service Consumption Value Market Share by Application (2021-2026)
5.2 Global Circular RNA Synthesis Service Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America Circular RNA Synthesis Service Consumption Value by Type (2021-2032)
6.2 North America Circular RNA Synthesis Service Market Size by Application (2021-2032)
6.3 North America Circular RNA Synthesis Service Market Size by Country
6.3.1 North America Circular RNA Synthesis Service Consumption Value by Country (2021-2032)
6.3.2 United States Circular RNA Synthesis Service Market Size and Forecast (2021-2032)
6.3.3 Canada Circular RNA Synthesis Service Market Size and Forecast (2021-2032)
6.3.4 Mexico Circular RNA Synthesis Service Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe Circular RNA Synthesis Service Consumption Value by Type (2021-2032)
7.2 Europe Circular RNA Synthesis Service Consumption Value by Application (2021-2032)
7.3 Europe Circular RNA Synthesis Service Market Size by Country
7.3.1 Europe Circular RNA Synthesis Service Consumption Value by Country (2021-2032)
7.3.2 Germany Circular RNA Synthesis Service Market Size and Forecast (2021-2032)
7.3.3 France Circular RNA Synthesis Service Market Size and Forecast (2021-2032)
7.3.4 United Kingdom Circular RNA Synthesis Service Market Size and Forecast (2021-2032)
7.3.5 Russia Circular RNA Synthesis Service Market Size and Forecast (2021-2032)
7.3.6 Italy Circular RNA Synthesis Service Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific Circular RNA Synthesis Service Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Circular RNA Synthesis Service Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Circular RNA Synthesis Service Market Size by Region
8.3.1 Asia-Pacific Circular RNA Synthesis Service Consumption Value by Region (2021-2032)
8.3.2 China Circular RNA Synthesis Service Market Size and Forecast (2021-2032)
8.3.3 Japan Circular RNA Synthesis Service Market Size and Forecast (2021-2032)
8.3.4 South Korea Circular RNA Synthesis Service Market Size and Forecast (2021-2032)
8.3.5 India Circular RNA Synthesis Service Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia Circular RNA Synthesis Service Market Size and Forecast (2021-2032)
8.3.7 Australia Circular RNA Synthesis Service Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America Circular RNA Synthesis Service Consumption Value by Type (2021-2032)
9.2 South America Circular RNA Synthesis Service Consumption Value by Application (2021-2032)
9.3 South America Circular RNA Synthesis Service Market Size by Country
9.3.1 South America Circular RNA Synthesis Service Consumption Value by Country (2021-2032)
9.3.2 Brazil Circular RNA Synthesis Service Market Size and Forecast (2021-2032)
9.3.3 Argentina Circular RNA Synthesis Service Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Circular RNA Synthesis Service Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Circular RNA Synthesis Service Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Circular RNA Synthesis Service Market Size by Country
10.3.1 Middle East & Africa Circular RNA Synthesis Service Consumption Value by Country (2021-2032)
10.3.2 Turkey Circular RNA Synthesis Service Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia Circular RNA Synthesis Service Market Size and Forecast (2021-2032)
10.3.4 UAE Circular RNA Synthesis Service Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 Circular RNA Synthesis Service Market Drivers
11.2 Circular RNA Synthesis Service Market Restraints
11.3 Circular RNA Synthesis Service Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Circular RNA Synthesis Service Industry Chain
12.2 Circular RNA Synthesis Service Upstream Analysis
12.3 Circular RNA Synthesis Service Midstream Analysis
12.4 Circular RNA Synthesis Service Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Circular RNA Synthesis Service by Type
1.3.1 Overview: Global Circular RNA Synthesis Service Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global Circular RNA Synthesis Service Consumption Value Market Share by Type in 2025
1.3.3 Custom Synthesis
1.3.4 Process Development
1.3.5 Analytical and QC Services
1.3.6 Other
1.4 Classification of Circular RNA Synthesis Service by Circularization Method
1.4.1 Overview: Global Circular RNA Synthesis Service Market Size by Circularization Method: 2021 Versus 2025 Versus 2032
1.4.2 Global Circular RNA Synthesis Service Consumption Value Market Share by Circularization Method in 2025
1.4.3 PIE Circularization
1.4.4 Enzymatic Ligation
1.4.5 Other
1.5 Classification of Circular RNA Synthesis Service by Product Format
1.5.1 Overview: Global Circular RNA Synthesis Service Market Size by Product Format: 2021 Versus 2025 Versus 2032
1.5.2 Global Circular RNA Synthesis Service Consumption Value Market Share by Product Format in 2025
1.5.3 Naked circRNA
1.5.4 circRNA-LNP
1.5.5 Other
1.6 Global Circular RNA Synthesis Service Market by Application
1.6.1 Overview: Global Circular RNA Synthesis Service Market Size by Application: 2021 Versus 2025 Versus 2032
1.6.2 Pharmaceutical and Biotechnology Companies
1.6.3 CRO and CDMO Companies
1.6.4 Other
1.7 Global Circular RNA Synthesis Service Market Size & Forecast
1.8 Global Circular RNA Synthesis Service Market Size and Forecast by Region
1.8.1 Global Circular RNA Synthesis Service Market Size by Region: 2021 VS 2025 VS 2032
1.8.2 Global Circular RNA Synthesis Service Market Size by Region, (2021-2032)
1.8.3 North America Circular RNA Synthesis Service Market Size and Prospect (2021-2032)
1.8.4 Europe Circular RNA Synthesis Service Market Size and Prospect (2021-2032)
1.8.5 Asia-Pacific Circular RNA Synthesis Service Market Size and Prospect (2021-2032)
1.8.6 South America Circular RNA Synthesis Service Market Size and Prospect (2021-2032)
1.8.7 Middle East & Africa Circular RNA Synthesis Service Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 GenScript Biotech Corporation
2.1.1 GenScript Biotech Corporation Details
2.1.2 GenScript Biotech Corporation Major Business
2.1.3 GenScript Biotech Corporation Circular RNA Synthesis Service Product and Solutions
2.1.4 GenScript Biotech Corporation Circular RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 GenScript Biotech Corporation Recent Developments and Future Plans
2.2 VectorBuilder
2.2.1 VectorBuilder Details
2.2.2 VectorBuilder Major Business
2.2.3 VectorBuilder Circular RNA Synthesis Service Product and Solutions
2.2.4 VectorBuilder Circular RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 VectorBuilder Recent Developments and Future Plans
2.3 Guangzhou Geneseed Biotech
2.3.1 Guangzhou Geneseed Biotech Details
2.3.2 Guangzhou Geneseed Biotech Major Business
2.3.3 Guangzhou Geneseed Biotech Circular RNA Synthesis Service Product and Solutions
2.3.4 Guangzhou Geneseed Biotech Circular RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Guangzhou Geneseed Biotech Recent Developments and Future Plans
2.4 uBriGene Biosciences
2.4.1 uBriGene Biosciences Details
2.4.2 uBriGene Biosciences Major Business
2.4.3 uBriGene Biosciences Circular RNA Synthesis Service Product and Solutions
2.4.4 uBriGene Biosciences Circular RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 uBriGene Biosciences Recent Developments and Future Plans
2.5 Yaohai Bio-Pharma
2.5.1 Yaohai Bio-Pharma Details
2.5.2 Yaohai Bio-Pharma Major Business
2.5.3 Yaohai Bio-Pharma Circular RNA Synthesis Service Product and Solutions
2.5.4 Yaohai Bio-Pharma Circular RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Yaohai Bio-Pharma Recent Developments and Future Plans
2.6 Creative Biogene
2.6.1 Creative Biogene Details
2.6.2 Creative Biogene Major Business
2.6.3 Creative Biogene Circular RNA Synthesis Service Product and Solutions
2.6.4 Creative Biogene Circular RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Creative Biogene Recent Developments and Future Plans
2.7 Creative Biolabs
2.7.1 Creative Biolabs Details
2.7.2 Creative Biolabs Major Business
2.7.3 Creative Biolabs Circular RNA Synthesis Service Product and Solutions
2.7.4 Creative Biolabs Circular RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Creative Biolabs Recent Developments and Future Plans
2.8 BOC Sciences
2.8.1 BOC Sciences Details
2.8.2 BOC Sciences Major Business
2.8.3 BOC Sciences Circular RNA Synthesis Service Product and Solutions
2.8.4 BOC Sciences Circular RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 BOC Sciences Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Circular RNA Synthesis Service Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of Circular RNA Synthesis Service by Company Revenue
3.2.2 Top 3 Circular RNA Synthesis Service Players Market Share in 2025
3.2.3 Top 6 Circular RNA Synthesis Service Players Market Share in 2025
3.3 Circular RNA Synthesis Service Market: Overall Company Footprint Analysis
3.3.1 Circular RNA Synthesis Service Market: Region Footprint
3.3.2 Circular RNA Synthesis Service Market: Company Product Type Footprint
3.3.3 Circular RNA Synthesis Service Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Circular RNA Synthesis Service Consumption Value and Market Share by Type (2021-2026)
4.2 Global Circular RNA Synthesis Service Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Circular RNA Synthesis Service Consumption Value Market Share by Application (2021-2026)
5.2 Global Circular RNA Synthesis Service Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America Circular RNA Synthesis Service Consumption Value by Type (2021-2032)
6.2 North America Circular RNA Synthesis Service Market Size by Application (2021-2032)
6.3 North America Circular RNA Synthesis Service Market Size by Country
6.3.1 North America Circular RNA Synthesis Service Consumption Value by Country (2021-2032)
6.3.2 United States Circular RNA Synthesis Service Market Size and Forecast (2021-2032)
6.3.3 Canada Circular RNA Synthesis Service Market Size and Forecast (2021-2032)
6.3.4 Mexico Circular RNA Synthesis Service Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe Circular RNA Synthesis Service Consumption Value by Type (2021-2032)
7.2 Europe Circular RNA Synthesis Service Consumption Value by Application (2021-2032)
7.3 Europe Circular RNA Synthesis Service Market Size by Country
7.3.1 Europe Circular RNA Synthesis Service Consumption Value by Country (2021-2032)
7.3.2 Germany Circular RNA Synthesis Service Market Size and Forecast (2021-2032)
7.3.3 France Circular RNA Synthesis Service Market Size and Forecast (2021-2032)
7.3.4 United Kingdom Circular RNA Synthesis Service Market Size and Forecast (2021-2032)
7.3.5 Russia Circular RNA Synthesis Service Market Size and Forecast (2021-2032)
7.3.6 Italy Circular RNA Synthesis Service Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific Circular RNA Synthesis Service Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Circular RNA Synthesis Service Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Circular RNA Synthesis Service Market Size by Region
8.3.1 Asia-Pacific Circular RNA Synthesis Service Consumption Value by Region (2021-2032)
8.3.2 China Circular RNA Synthesis Service Market Size and Forecast (2021-2032)
8.3.3 Japan Circular RNA Synthesis Service Market Size and Forecast (2021-2032)
8.3.4 South Korea Circular RNA Synthesis Service Market Size and Forecast (2021-2032)
8.3.5 India Circular RNA Synthesis Service Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia Circular RNA Synthesis Service Market Size and Forecast (2021-2032)
8.3.7 Australia Circular RNA Synthesis Service Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America Circular RNA Synthesis Service Consumption Value by Type (2021-2032)
9.2 South America Circular RNA Synthesis Service Consumption Value by Application (2021-2032)
9.3 South America Circular RNA Synthesis Service Market Size by Country
9.3.1 South America Circular RNA Synthesis Service Consumption Value by Country (2021-2032)
9.3.2 Brazil Circular RNA Synthesis Service Market Size and Forecast (2021-2032)
9.3.3 Argentina Circular RNA Synthesis Service Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Circular RNA Synthesis Service Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Circular RNA Synthesis Service Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Circular RNA Synthesis Service Market Size by Country
10.3.1 Middle East & Africa Circular RNA Synthesis Service Consumption Value by Country (2021-2032)
10.3.2 Turkey Circular RNA Synthesis Service Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia Circular RNA Synthesis Service Market Size and Forecast (2021-2032)
10.3.4 UAE Circular RNA Synthesis Service Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 Circular RNA Synthesis Service Market Drivers
11.2 Circular RNA Synthesis Service Market Restraints
11.3 Circular RNA Synthesis Service Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Circular RNA Synthesis Service Industry Chain
12.2 Circular RNA Synthesis Service Upstream Analysis
12.3 Circular RNA Synthesis Service Midstream Analysis
12.4 Circular RNA Synthesis Service Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Circular RNA Synthesis Service Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Circular RNA Synthesis Service Consumption Value by Circularization Method, (USD Million), 2021 & 2025 & 2032
Table 3. Global Circular RNA Synthesis Service Consumption Value by Product Format, (USD Million), 2021 & 2025 & 2032
Table 4. Global Circular RNA Synthesis Service Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Global Circular RNA Synthesis Service Consumption Value by Region (2021-2026) & (USD Million)
Table 6. Global Circular RNA Synthesis Service Consumption Value by Region (2027-2032) & (USD Million)
Table 7. GenScript Biotech Corporation Company Information, Head Office, and Major Competitors
Table 8. GenScript Biotech Corporation Major Business
Table 9. GenScript Biotech Corporation Circular RNA Synthesis Service Product and Solutions
Table 10. GenScript Biotech Corporation Circular RNA Synthesis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 11. GenScript Biotech Corporation Recent Developments and Future Plans
Table 12. VectorBuilder Company Information, Head Office, and Major Competitors
Table 13. VectorBuilder Major Business
Table 14. VectorBuilder Circular RNA Synthesis Service Product and Solutions
Table 15. VectorBuilder Circular RNA Synthesis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 16. VectorBuilder Recent Developments and Future Plans
Table 17. Guangzhou Geneseed Biotech Company Information, Head Office, and Major Competitors
Table 18. Guangzhou Geneseed Biotech Major Business
Table 19. Guangzhou Geneseed Biotech Circular RNA Synthesis Service Product and Solutions
Table 20. Guangzhou Geneseed Biotech Circular RNA Synthesis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 21. uBriGene Biosciences Company Information, Head Office, and Major Competitors
Table 22. uBriGene Biosciences Major Business
Table 23. uBriGene Biosciences Circular RNA Synthesis Service Product and Solutions
Table 24. uBriGene Biosciences Circular RNA Synthesis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 25. uBriGene Biosciences Recent Developments and Future Plans
Table 26. Yaohai Bio-Pharma Company Information, Head Office, and Major Competitors
Table 27. Yaohai Bio-Pharma Major Business
Table 28. Yaohai Bio-Pharma Circular RNA Synthesis Service Product and Solutions
Table 29. Yaohai Bio-Pharma Circular RNA Synthesis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 30. Yaohai Bio-Pharma Recent Developments and Future Plans
Table 31. Creative Biogene Company Information, Head Office, and Major Competitors
Table 32. Creative Biogene Major Business
Table 33. Creative Biogene Circular RNA Synthesis Service Product and Solutions
Table 34. Creative Biogene Circular RNA Synthesis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 35. Creative Biogene Recent Developments and Future Plans
Table 36. Creative Biolabs Company Information, Head Office, and Major Competitors
Table 37. Creative Biolabs Major Business
Table 38. Creative Biolabs Circular RNA Synthesis Service Product and Solutions
Table 39. Creative Biolabs Circular RNA Synthesis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 40. Creative Biolabs Recent Developments and Future Plans
Table 41. BOC Sciences Company Information, Head Office, and Major Competitors
Table 42. BOC Sciences Major Business
Table 43. BOC Sciences Circular RNA Synthesis Service Product and Solutions
Table 44. BOC Sciences Circular RNA Synthesis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 45. BOC Sciences Recent Developments and Future Plans
Table 46. Global Circular RNA Synthesis Service Revenue (USD Million) by Players (2021-2026)
Table 47. Global Circular RNA Synthesis Service Revenue Share by Players (2021-2026)
Table 48. Breakdown of Circular RNA Synthesis Service by Company Type (Tier 1, Tier 2, and Tier 3)
Table 49. Market Position of Players in Circular RNA Synthesis Service, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 50. Head Office of Key Circular RNA Synthesis Service Players
Table 51. Circular RNA Synthesis Service Market: Company Product Type Footprint
Table 52. Circular RNA Synthesis Service Market: Company Product Application Footprint
Table 53. Circular RNA Synthesis Service New Market Entrants and Barriers to Market Entry
Table 54. Circular RNA Synthesis Service Mergers, Acquisition, Agreements, and Collaborations
Table 55. Global Circular RNA Synthesis Service Consumption Value (USD Million) by Type (2021-2026)
Table 56. Global Circular RNA Synthesis Service Consumption Value Share by Type (2021-2026)
Table 57. Global Circular RNA Synthesis Service Consumption Value Forecast by Type (2027-2032)
Table 58. Global Circular RNA Synthesis Service Consumption Value by Application (2021-2026)
Table 59. Global Circular RNA Synthesis Service Consumption Value Forecast by Application (2027-2032)
Table 60. North America Circular RNA Synthesis Service Consumption Value by Type (2021-2026) & (USD Million)
Table 61. North America Circular RNA Synthesis Service Consumption Value by Type (2027-2032) & (USD Million)
Table 62. North America Circular RNA Synthesis Service Consumption Value by Application (2021-2026) & (USD Million)
Table 63. North America Circular RNA Synthesis Service Consumption Value by Application (2027-2032) & (USD Million)
Table 64. North America Circular RNA Synthesis Service Consumption Value by Country (2021-2026) & (USD Million)
Table 65. North America Circular RNA Synthesis Service Consumption Value by Country (2027-2032) & (USD Million)
Table 66. Europe Circular RNA Synthesis Service Consumption Value by Type (2021-2026) & (USD Million)
Table 67. Europe Circular RNA Synthesis Service Consumption Value by Type (2027-2032) & (USD Million)
Table 68. Europe Circular RNA Synthesis Service Consumption Value by Application (2021-2026) & (USD Million)
Table 69. Europe Circular RNA Synthesis Service Consumption Value by Application (2027-2032) & (USD Million)
Table 70. Europe Circular RNA Synthesis Service Consumption Value by Country (2021-2026) & (USD Million)
Table 71. Europe Circular RNA Synthesis Service Consumption Value by Country (2027-2032) & (USD Million)
Table 72. Asia-Pacific Circular RNA Synthesis Service Consumption Value by Type (2021-2026) & (USD Million)
Table 73. Asia-Pacific Circular RNA Synthesis Service Consumption Value by Type (2027-2032) & (USD Million)
Table 74. Asia-Pacific Circular RNA Synthesis Service Consumption Value by Application (2021-2026) & (USD Million)
Table 75. Asia-Pacific Circular RNA Synthesis Service Consumption Value by Application (2027-2032) & (USD Million)
Table 76. Asia-Pacific Circular RNA Synthesis Service Consumption Value by Region (2021-2026) & (USD Million)
Table 77. Asia-Pacific Circular RNA Synthesis Service Consumption Value by Region (2027-2032) & (USD Million)
Table 78. South America Circular RNA Synthesis Service Consumption Value by Type (2021-2026) & (USD Million)
Table 79. South America Circular RNA Synthesis Service Consumption Value by Type (2027-2032) & (USD Million)
Table 80. South America Circular RNA Synthesis Service Consumption Value by Application (2021-2026) & (USD Million)
Table 81. South America Circular RNA Synthesis Service Consumption Value by Application (2027-2032) & (USD Million)
Table 82. South America Circular RNA Synthesis Service Consumption Value by Country (2021-2026) & (USD Million)
Table 83. South America Circular RNA Synthesis Service Consumption Value by Country (2027-2032) & (USD Million)
Table 84. Middle East & Africa Circular RNA Synthesis Service Consumption Value by Type (2021-2026) & (USD Million)
Table 85. Middle East & Africa Circular RNA Synthesis Service Consumption Value by Type (2027-2032) & (USD Million)
Table 86. Middle East & Africa Circular RNA Synthesis Service Consumption Value by Application (2021-2026) & (USD Million)
Table 87. Middle East & Africa Circular RNA Synthesis Service Consumption Value by Application (2027-2032) & (USD Million)
Table 88. Middle East & Africa Circular RNA Synthesis Service Consumption Value by Country (2021-2026) & (USD Million)
Table 89. Middle East & Africa Circular RNA Synthesis Service Consumption Value by Country (2027-2032) & (USD Million)
Table 90. Global Key Players of Circular RNA Synthesis Service Upstream (Raw Materials)
Table 91. Global Circular RNA Synthesis Service Typical Customers
Table 1. Global Circular RNA Synthesis Service Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Circular RNA Synthesis Service Consumption Value by Circularization Method, (USD Million), 2021 & 2025 & 2032
Table 3. Global Circular RNA Synthesis Service Consumption Value by Product Format, (USD Million), 2021 & 2025 & 2032
Table 4. Global Circular RNA Synthesis Service Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Global Circular RNA Synthesis Service Consumption Value by Region (2021-2026) & (USD Million)
Table 6. Global Circular RNA Synthesis Service Consumption Value by Region (2027-2032) & (USD Million)
Table 7. GenScript Biotech Corporation Company Information, Head Office, and Major Competitors
Table 8. GenScript Biotech Corporation Major Business
Table 9. GenScript Biotech Corporation Circular RNA Synthesis Service Product and Solutions
Table 10. GenScript Biotech Corporation Circular RNA Synthesis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 11. GenScript Biotech Corporation Recent Developments and Future Plans
Table 12. VectorBuilder Company Information, Head Office, and Major Competitors
Table 13. VectorBuilder Major Business
Table 14. VectorBuilder Circular RNA Synthesis Service Product and Solutions
Table 15. VectorBuilder Circular RNA Synthesis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 16. VectorBuilder Recent Developments and Future Plans
Table 17. Guangzhou Geneseed Biotech Company Information, Head Office, and Major Competitors
Table 18. Guangzhou Geneseed Biotech Major Business
Table 19. Guangzhou Geneseed Biotech Circular RNA Synthesis Service Product and Solutions
Table 20. Guangzhou Geneseed Biotech Circular RNA Synthesis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 21. uBriGene Biosciences Company Information, Head Office, and Major Competitors
Table 22. uBriGene Biosciences Major Business
Table 23. uBriGene Biosciences Circular RNA Synthesis Service Product and Solutions
Table 24. uBriGene Biosciences Circular RNA Synthesis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 25. uBriGene Biosciences Recent Developments and Future Plans
Table 26. Yaohai Bio-Pharma Company Information, Head Office, and Major Competitors
Table 27. Yaohai Bio-Pharma Major Business
Table 28. Yaohai Bio-Pharma Circular RNA Synthesis Service Product and Solutions
Table 29. Yaohai Bio-Pharma Circular RNA Synthesis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 30. Yaohai Bio-Pharma Recent Developments and Future Plans
Table 31. Creative Biogene Company Information, Head Office, and Major Competitors
Table 32. Creative Biogene Major Business
Table 33. Creative Biogene Circular RNA Synthesis Service Product and Solutions
Table 34. Creative Biogene Circular RNA Synthesis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 35. Creative Biogene Recent Developments and Future Plans
Table 36. Creative Biolabs Company Information, Head Office, and Major Competitors
Table 37. Creative Biolabs Major Business
Table 38. Creative Biolabs Circular RNA Synthesis Service Product and Solutions
Table 39. Creative Biolabs Circular RNA Synthesis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 40. Creative Biolabs Recent Developments and Future Plans
Table 41. BOC Sciences Company Information, Head Office, and Major Competitors
Table 42. BOC Sciences Major Business
Table 43. BOC Sciences Circular RNA Synthesis Service Product and Solutions
Table 44. BOC Sciences Circular RNA Synthesis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 45. BOC Sciences Recent Developments and Future Plans
Table 46. Global Circular RNA Synthesis Service Revenue (USD Million) by Players (2021-2026)
Table 47. Global Circular RNA Synthesis Service Revenue Share by Players (2021-2026)
Table 48. Breakdown of Circular RNA Synthesis Service by Company Type (Tier 1, Tier 2, and Tier 3)
Table 49. Market Position of Players in Circular RNA Synthesis Service, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 50. Head Office of Key Circular RNA Synthesis Service Players
Table 51. Circular RNA Synthesis Service Market: Company Product Type Footprint
Table 52. Circular RNA Synthesis Service Market: Company Product Application Footprint
Table 53. Circular RNA Synthesis Service New Market Entrants and Barriers to Market Entry
Table 54. Circular RNA Synthesis Service Mergers, Acquisition, Agreements, and Collaborations
Table 55. Global Circular RNA Synthesis Service Consumption Value (USD Million) by Type (2021-2026)
Table 56. Global Circular RNA Synthesis Service Consumption Value Share by Type (2021-2026)
Table 57. Global Circular RNA Synthesis Service Consumption Value Forecast by Type (2027-2032)
Table 58. Global Circular RNA Synthesis Service Consumption Value by Application (2021-2026)
Table 59. Global Circular RNA Synthesis Service Consumption Value Forecast by Application (2027-2032)
Table 60. North America Circular RNA Synthesis Service Consumption Value by Type (2021-2026) & (USD Million)
Table 61. North America Circular RNA Synthesis Service Consumption Value by Type (2027-2032) & (USD Million)
Table 62. North America Circular RNA Synthesis Service Consumption Value by Application (2021-2026) & (USD Million)
Table 63. North America Circular RNA Synthesis Service Consumption Value by Application (2027-2032) & (USD Million)
Table 64. North America Circular RNA Synthesis Service Consumption Value by Country (2021-2026) & (USD Million)
Table 65. North America Circular RNA Synthesis Service Consumption Value by Country (2027-2032) & (USD Million)
Table 66. Europe Circular RNA Synthesis Service Consumption Value by Type (2021-2026) & (USD Million)
Table 67. Europe Circular RNA Synthesis Service Consumption Value by Type (2027-2032) & (USD Million)
Table 68. Europe Circular RNA Synthesis Service Consumption Value by Application (2021-2026) & (USD Million)
Table 69. Europe Circular RNA Synthesis Service Consumption Value by Application (2027-2032) & (USD Million)
Table 70. Europe Circular RNA Synthesis Service Consumption Value by Country (2021-2026) & (USD Million)
Table 71. Europe Circular RNA Synthesis Service Consumption Value by Country (2027-2032) & (USD Million)
Table 72. Asia-Pacific Circular RNA Synthesis Service Consumption Value by Type (2021-2026) & (USD Million)
Table 73. Asia-Pacific Circular RNA Synthesis Service Consumption Value by Type (2027-2032) & (USD Million)
Table 74. Asia-Pacific Circular RNA Synthesis Service Consumption Value by Application (2021-2026) & (USD Million)
Table 75. Asia-Pacific Circular RNA Synthesis Service Consumption Value by Application (2027-2032) & (USD Million)
Table 76. Asia-Pacific Circular RNA Synthesis Service Consumption Value by Region (2021-2026) & (USD Million)
Table 77. Asia-Pacific Circular RNA Synthesis Service Consumption Value by Region (2027-2032) & (USD Million)
Table 78. South America Circular RNA Synthesis Service Consumption Value by Type (2021-2026) & (USD Million)
Table 79. South America Circular RNA Synthesis Service Consumption Value by Type (2027-2032) & (USD Million)
Table 80. South America Circular RNA Synthesis Service Consumption Value by Application (2021-2026) & (USD Million)
Table 81. South America Circular RNA Synthesis Service Consumption Value by Application (2027-2032) & (USD Million)
Table 82. South America Circular RNA Synthesis Service Consumption Value by Country (2021-2026) & (USD Million)
Table 83. South America Circular RNA Synthesis Service Consumption Value by Country (2027-2032) & (USD Million)
Table 84. Middle East & Africa Circular RNA Synthesis Service Consumption Value by Type (2021-2026) & (USD Million)
Table 85. Middle East & Africa Circular RNA Synthesis Service Consumption Value by Type (2027-2032) & (USD Million)
Table 86. Middle East & Africa Circular RNA Synthesis Service Consumption Value by Application (2021-2026) & (USD Million)
Table 87. Middle East & Africa Circular RNA Synthesis Service Consumption Value by Application (2027-2032) & (USD Million)
Table 88. Middle East & Africa Circular RNA Synthesis Service Consumption Value by Country (2021-2026) & (USD Million)
Table 89. Middle East & Africa Circular RNA Synthesis Service Consumption Value by Country (2027-2032) & (USD Million)
Table 90. Global Key Players of Circular RNA Synthesis Service Upstream (Raw Materials)
Table 91. Global Circular RNA Synthesis Service Typical Customers
LIST OF FIGURES
Figure 1. Circular RNA Synthesis Service Picture
Figure 2. Global Circular RNA Synthesis Service Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Circular RNA Synthesis Service Consumption Value Market Share by Type in 2025
Figure 4. Custom Synthesis
Figure 5. Process Development
Figure 6. Analytical and QC Services
Figure 7. Other
Figure 8. Global Circular RNA Synthesis Service Consumption Value by Circularization Method, (USD Million), 2021 & 2025 & 2032
Figure 9. Global Circular RNA Synthesis Service Consumption Value Market Share by Circularization Method in 2025
Figure 10. PIE Circularization
Figure 11. Enzymatic Ligation
Figure 12. Other
Figure 13. Global Circular RNA Synthesis Service Consumption Value by Product Format, (USD Million), 2021 & 2025 & 2032
Figure 14. Global Circular RNA Synthesis Service Consumption Value Market Share by Product Format in 2025
Figure 15. Naked circRNA
Figure 16. circRNA-LNP
Figure 17. Other
Figure 18. Global Circular RNA Synthesis Service Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 19. Circular RNA Synthesis Service Consumption Value Market Share by Application in 2025
Figure 20. Pharmaceutical and Biotechnology Companies Picture
Figure 21. CRO and CDMO Companies Picture
Figure 22. Other Picture
Figure 23. Global Circular RNA Synthesis Service Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 24. Global Circular RNA Synthesis Service Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 25. Global Market Circular RNA Synthesis Service Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 26. Global Circular RNA Synthesis Service Consumption Value Market Share by Region (2021-2032)
Figure 27. Global Circular RNA Synthesis Service Consumption Value Market Share by Region in 2025
Figure 28. North America Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 29. Europe Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 30. Asia-Pacific Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 31. South America Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 32. Middle East & Africa Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 33. Company Three Recent Developments and Future Plans
Figure 34. Global Circular RNA Synthesis Service Revenue Share by Players in 2025
Figure 35. Circular RNA Synthesis Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 36. Market Share of Circular RNA Synthesis Service by Player Revenue in 2025
Figure 37. Top 3 Circular RNA Synthesis Service Players Market Share in 2025
Figure 38. Top 6 Circular RNA Synthesis Service Players Market Share in 2025
Figure 39. Global Circular RNA Synthesis Service Consumption Value Share by Type (2021-2026)
Figure 40. Global Circular RNA Synthesis Service Market Share Forecast by Type (2027-2032)
Figure 41. Global Circular RNA Synthesis Service Consumption Value Share by Application (2021-2026)
Figure 42. Global Circular RNA Synthesis Service Market Share Forecast by Application (2027-2032)
Figure 43. North America Circular RNA Synthesis Service Consumption Value Market Share by Type (2021-2032)
Figure 44. North America Circular RNA Synthesis Service Consumption Value Market Share by Application (2021-2032)
Figure 45. North America Circular RNA Synthesis Service Consumption Value Market Share by Country (2021-2032)
Figure 46. United States Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 47. Canada Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 48. Mexico Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 49. Europe Circular RNA Synthesis Service Consumption Value Market Share by Type (2021-2032)
Figure 50. Europe Circular RNA Synthesis Service Consumption Value Market Share by Application (2021-2032)
Figure 51. Europe Circular RNA Synthesis Service Consumption Value Market Share by Country (2021-2032)
Figure 52. Germany Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 53. France Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 54. United Kingdom Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 55. Russia Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 56. Italy Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 57. Asia-Pacific Circular RNA Synthesis Service Consumption Value Market Share by Type (2021-2032)
Figure 58. Asia-Pacific Circular RNA Synthesis Service Consumption Value Market Share by Application (2021-2032)
Figure 59. Asia-Pacific Circular RNA Synthesis Service Consumption Value Market Share by Region (2021-2032)
Figure 60. China Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 61. Japan Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 62. South Korea Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 63. India Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 64. Southeast Asia Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 65. Australia Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 66. South America Circular RNA Synthesis Service Consumption Value Market Share by Type (2021-2032)
Figure 67. South America Circular RNA Synthesis Service Consumption Value Market Share by Application (2021-2032)
Figure 68. South America Circular RNA Synthesis Service Consumption Value Market Share by Country (2021-2032)
Figure 69. Brazil Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 70. Argentina Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 71. Middle East & Africa Circular RNA Synthesis Service Consumption Value Market Share by Type (2021-2032)
Figure 72. Middle East & Africa Circular RNA Synthesis Service Consumption Value Market Share by Application (2021-2032)
Figure 73. Middle East & Africa Circular RNA Synthesis Service Consumption Value Market Share by Country (2021-2032)
Figure 74. Turkey Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 75. Saudi Arabia Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 76. UAE Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 77. Circular RNA Synthesis Service Market Drivers
Figure 78. Circular RNA Synthesis Service Market Restraints
Figure 79. Circular RNA Synthesis Service Market Trends
Figure 80. Porters Five Forces Analysis
Figure 81. Circular RNA Synthesis Service Industrial Chain
Figure 82. Methodology
Figure 83. Research Process and Data Source
Figure 1. Circular RNA Synthesis Service Picture
Figure 2. Global Circular RNA Synthesis Service Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Circular RNA Synthesis Service Consumption Value Market Share by Type in 2025
Figure 4. Custom Synthesis
Figure 5. Process Development
Figure 6. Analytical and QC Services
Figure 7. Other
Figure 8. Global Circular RNA Synthesis Service Consumption Value by Circularization Method, (USD Million), 2021 & 2025 & 2032
Figure 9. Global Circular RNA Synthesis Service Consumption Value Market Share by Circularization Method in 2025
Figure 10. PIE Circularization
Figure 11. Enzymatic Ligation
Figure 12. Other
Figure 13. Global Circular RNA Synthesis Service Consumption Value by Product Format, (USD Million), 2021 & 2025 & 2032
Figure 14. Global Circular RNA Synthesis Service Consumption Value Market Share by Product Format in 2025
Figure 15. Naked circRNA
Figure 16. circRNA-LNP
Figure 17. Other
Figure 18. Global Circular RNA Synthesis Service Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 19. Circular RNA Synthesis Service Consumption Value Market Share by Application in 2025
Figure 20. Pharmaceutical and Biotechnology Companies Picture
Figure 21. CRO and CDMO Companies Picture
Figure 22. Other Picture
Figure 23. Global Circular RNA Synthesis Service Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 24. Global Circular RNA Synthesis Service Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 25. Global Market Circular RNA Synthesis Service Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 26. Global Circular RNA Synthesis Service Consumption Value Market Share by Region (2021-2032)
Figure 27. Global Circular RNA Synthesis Service Consumption Value Market Share by Region in 2025
Figure 28. North America Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 29. Europe Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 30. Asia-Pacific Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 31. South America Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 32. Middle East & Africa Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 33. Company Three Recent Developments and Future Plans
Figure 34. Global Circular RNA Synthesis Service Revenue Share by Players in 2025
Figure 35. Circular RNA Synthesis Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 36. Market Share of Circular RNA Synthesis Service by Player Revenue in 2025
Figure 37. Top 3 Circular RNA Synthesis Service Players Market Share in 2025
Figure 38. Top 6 Circular RNA Synthesis Service Players Market Share in 2025
Figure 39. Global Circular RNA Synthesis Service Consumption Value Share by Type (2021-2026)
Figure 40. Global Circular RNA Synthesis Service Market Share Forecast by Type (2027-2032)
Figure 41. Global Circular RNA Synthesis Service Consumption Value Share by Application (2021-2026)
Figure 42. Global Circular RNA Synthesis Service Market Share Forecast by Application (2027-2032)
Figure 43. North America Circular RNA Synthesis Service Consumption Value Market Share by Type (2021-2032)
Figure 44. North America Circular RNA Synthesis Service Consumption Value Market Share by Application (2021-2032)
Figure 45. North America Circular RNA Synthesis Service Consumption Value Market Share by Country (2021-2032)
Figure 46. United States Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 47. Canada Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 48. Mexico Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 49. Europe Circular RNA Synthesis Service Consumption Value Market Share by Type (2021-2032)
Figure 50. Europe Circular RNA Synthesis Service Consumption Value Market Share by Application (2021-2032)
Figure 51. Europe Circular RNA Synthesis Service Consumption Value Market Share by Country (2021-2032)
Figure 52. Germany Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 53. France Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 54. United Kingdom Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 55. Russia Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 56. Italy Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 57. Asia-Pacific Circular RNA Synthesis Service Consumption Value Market Share by Type (2021-2032)
Figure 58. Asia-Pacific Circular RNA Synthesis Service Consumption Value Market Share by Application (2021-2032)
Figure 59. Asia-Pacific Circular RNA Synthesis Service Consumption Value Market Share by Region (2021-2032)
Figure 60. China Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 61. Japan Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 62. South Korea Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 63. India Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 64. Southeast Asia Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 65. Australia Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 66. South America Circular RNA Synthesis Service Consumption Value Market Share by Type (2021-2032)
Figure 67. South America Circular RNA Synthesis Service Consumption Value Market Share by Application (2021-2032)
Figure 68. South America Circular RNA Synthesis Service Consumption Value Market Share by Country (2021-2032)
Figure 69. Brazil Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 70. Argentina Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 71. Middle East & Africa Circular RNA Synthesis Service Consumption Value Market Share by Type (2021-2032)
Figure 72. Middle East & Africa Circular RNA Synthesis Service Consumption Value Market Share by Application (2021-2032)
Figure 73. Middle East & Africa Circular RNA Synthesis Service Consumption Value Market Share by Country (2021-2032)
Figure 74. Turkey Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 75. Saudi Arabia Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 76. UAE Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 77. Circular RNA Synthesis Service Market Drivers
Figure 78. Circular RNA Synthesis Service Market Restraints
Figure 79. Circular RNA Synthesis Service Market Trends
Figure 80. Porters Five Forces Analysis
Figure 81. Circular RNA Synthesis Service Industrial Chain
Figure 82. Methodology
Figure 83. Research Process and Data Source
